Immunotherapy for metastatic melanoma
✍
Christopher R. Zito; Harriet M. Kluger
📂
Article
📅
2012
🏛
John Wiley and Sons
🌐
English
⚖ 118 KB
## Abstract Melanoma has traditionally been considered an immunogenic tumor. A number of approaches have been studied for enhancement of antitumor immunity. The first cytokine approved for the treatment of metastatic melanoma, interleukin‐2, has resulted in prolonged responses in a small subset of